SCHEMBL8539176

SCHEMBL8539176

Cc1ccc2c(c1)c(-c1ccccc1Cl)c(N)c(=O)n2C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.43
MAPT P10636 2/20 0.43
ALDH1A1 P00352 2/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
USP2 O75604 1/20 0.43
KEAP1 Q14145 1/20 0.43
NFE2L2 Q16236 1/20 0.43
MAT2A P31153 1/20 0.40
CHEK1 O14757 1/20 0.40
WEE1 P30291 1/20 0.40
APAF1 O14727 1/20 0.40
PKM P14618 1/20 0.40
IDO1 P14902 1/20 0.40
MAPK1 P28482 1/20 0.40
HTT P42858 1/20 0.40
RAB9A P51151 1/20 0.40
MCL1 Q07820 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
TDP1 Q9NUW8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8543014 0.88 KDM4E (0.44) KDM4EMAPTALDH1A1MEN1KMT2A
SCHEMBL9359195 0.86 CYP1A1 (0.43) KDM4EMAPTALDH1A1MEN1KMT2A
SCHEMBL8541594 0.84 KDM4E (0.44) KDM4EMAPTALDH1A1MEN1KMT2A
SCHEMBL8538348 0.84 PGR (0.42) KDM4EMAPTALDH1A1MEN1KMT2A
SCHEMBL9092464 0.81 CYP1A1 (0.41) KDM4EMAPTALDH1A1MEN1KMT2A
SCHEMBL30574986 0.79 WEE1 (0.44) KDM4EMAPTALDH1A1MEN1KMT2A
SCHEMBL31223936 0.71 KDM4E (0.44) KDM4EMAPTALDH1A1MEN1KMT2A
SCHEMBL8544183 0.71 POLB (0.37) MAPTMEN1KMT2AMAT2ACHEK1
SCHEMBL27312009 0.70 MAT2A (0.39) MAPTMAT2ACHEK1WEE1MAPK1
SCHEMBL8544707 0.70 KMT2A (0.47) KDM4EMAPTMEN1KMT2ACHEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0623112-B1 4-Phenyl-3-(heteroarylureido)-1,2-dihydro-2-oxoquinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents PFIZER (US) 1998-12-30 EP disclosed
US-5565472-A 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents PFIZER INC. (US) 1996-10-15 US disclosed
EP-0623112-A1 4-ARYL-3-(HETEROARYLUREIDO)-1,2-DIHYDRO-2-OXO-QUINOLINE DERIVATIVES AS ANTIHYPERCHOLESTEROLEMIC AND ANTIATHEROSCLEROTIC AGENTS PFIZER INC. (US) 1994-11-09 EP disclosed
WO-1993015058-A1 4-ARYL-3-(HETEROARYLUREIDO)-1,2-DIHYDRO-2-OXO-QUINOLINE DERIVATIVES AS ANTIHYPERCHOLESTEROLEMIC AND ANTIATHEROSCLEROTIC AGENTS PFIZER INC. (US) 1993-08-05 WO disclosed